ong term follow-up protocol of prospective cohort study on bone mineral density changes in the stage 1 or 2 gastric cancer patients after gastrectomy
Not Applicable
Recruiting
- Conditions
- gastric cancer
- Registration Number
- JPRN-UMIN000043647
- Lead Sponsor
- Kindai University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 170
Inclusion Criteria
Not provided
Exclusion Criteria
The patients who fall under the any of criteria for discontinuing LOHAS Study
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular pathways link gastrectomy to bone mineral density loss in early gastric cancer patients?
How does total vs. subtotal gastrectomy affect long-term bone mineral density in stage 1/2 gastric cancer patients?
Which nutritional or genetic biomarkers predict post-gastrectomy bone mineral density decline in gastric cancer survivors?
What are the long-term fracture risks associated with bone mineral density changes after gastrectomy for gastric cancer?
How effective are RANKL inhibitors like denosumab in preventing post-gastrectomy bone loss in gastric cancer patients?